Skip to main content
    H

    HeartSciences Inc. (HSCS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.08
    -0.04 (-2.12%)

    Market Cap: $10.56M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    HeartSciences Inc. (HSCS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect HeartSciences (HSCS) to earn -$2.46 per share in the fiscal year ending Apr 30, 2027, on revenue of $17100. Over the last 30 days, 1 estimate for the fiscal year ending Apr 30, 2027 was revised up and 0 down. For the fiscal year ending Apr 30, 2028, the EPS consensus is -$1.75.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 18321.1%.

    Fiscal year ending Apr 30, 2027
    -$2.46
    EPS consensus, revenue $17100
    Fiscal year ending Apr 30, 2028
    -$1.75
    EPS consensus, revenue $3.15M
    Next report
    Dec 21, 2026
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Apr 30, 2027-$2.46-$2.46 to -$2.461$17100$17100 to $171001
    Apr 30, 2028-$1.75-$1.75 to -$1.751$3.15M$3.15M to $3.15M1

    Quarterly Estimates

    The EPS consensus falls from -$0.61 for the quarter ending Jan 31, 2027 to -$0.65 for the quarter ending Apr 30, 2027.

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Jan 31, 2027-$0.61-$0.61 to -$0.611$5000$5000 to $50001
    Apr 30, 2027-$0.65N/A3$10200$9800 to $105003

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Apr 30, 202710
    Fiscal year ending Apr 30, 202810
    Quarter ending Jan 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Apr 30, 2027 has improved from -$2.83.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Apr 30, 2027-$2.46-$2.46-$2.62-$2.62-$2.83N/A
    Fiscal year ending Apr 30, 2028-$1.75-$1.86-$1.86-$1.93-$1.93N/A
    Quarter ending Jan 31, 2027-$0.61-$0.61-$0.66-$0.66-$0.72N/A

    Frequently Asked Questions About HSCS

    What is the HSCS stock forecast?

    Consensus analyst estimates put HeartSciences's EPS at -$2.46 for the fiscal year ending Apr 30, 2027, on revenue of $17100.

    What EPS do analysts expect from HSCS next year?

    For the fiscal year ending Apr 30, 2027, the consensus EPS estimate is -$2.46, with estimates from -$2.46 to -$2.46 from 1 analyst. For the fiscal year ending Apr 30, 2028, the consensus EPS estimate is -$1.75, with estimates from -$1.75 to -$1.75 from 1 analyst.

    What revenue do analysts expect from HeartSciences next year?

    For the fiscal year ending Apr 30, 2027, the consensus revenue estimate is $17100, with estimates from $17100 to $17100. For the fiscal year ending Apr 30, 2028, the consensus revenue estimate is $3.15M, with estimates from $3.15M to $3.15M.

    How many analysts cover HSCS?

    1 analyst estimates EPS for HeartSciences for the fiscal year ending Apr 30, 2027.